<DOC>
	<DOCNO>NCT01628770</DOCNO>
	<brief_summary>The investigator hypothesize isomaltoside 1000 ( Monofer ) , oral iron preparation equally effective correction postpartum iron deficiency anemia .</brief_summary>
	<brief_title>Use Iron Isomaltoside 1000 ( Monofer ) Postpartum Anemia</brief_title>
	<detailed_description>Iron molecule iron isomaltoside 1000 ( Monofer ) introduce market , give intravenous infusion form , relatively short period time , single setting , calculation require dose . This preparation use treatment anemia patient chronic renal disease , gastrointestinal disorder , anemia malignancy gynecological disorder . It require test dose give total dose , require premedication . It give dose 20mg/kg . The drug license use Europe 2009 . It use treatment anemia patient chronic renal disease , inflammatory bowel disease anemia due malignancy</detailed_description>
	<mesh_term>Anemia</mesh_term>
	<mesh_term>Iron</mesh_term>
	<mesh_term>Ferric Compounds</mesh_term>
	<criteria>Women within 2448 hour delivery hemoglobin concentration &lt; 10gm/dl History PPH , significant blood loss last 24 hour History allergy iron preparation Hemoglobin &lt; 7gm/dl . Sign &amp; symptom cardiac failure H/o blood transfusion last 3 month H/O Chronic liver disease . â†‘ Creatinine &gt; 2mg/dl .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>iron</keyword>
	<keyword>monofer</keyword>
	<keyword>Pakistan</keyword>
</DOC>